Rifaximin overdosage

Rifaximin
XIFAXAN^® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]

Overdosage

No specific information is available on the treatment of overdosage with XIFAXAN. In clinical studies at doses higher than the recommended dose (> 600 mg/day for travelers’ diarrhea or > 1100 mg/day for hepatic encephalopathy), adverse reactions were similar in subjects who received doses higher than the recommended dose and placebo. In the case of overdosage, discontinue XIFAXAN, treat symptomatically, and institute supportive measures as required.^[1]

References

↑ “XIFAXAN (RIFAXIMIN) TABLET [SALIX PHARMACEUTICALS, INC.]”.

Adapted from the FDA Package Insert.

[dailymed.nlm.nih.gov-1] “XIFAXAN (RIFAXIMIN) TABLET [SALIX PHARMACEUTICALS, INC.]”.

[1]

Rifaximin overdosage

Overdosage

References

Looking for the patient version?